CME Group Inc. (CME) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
CME Group’s revenue went from $3.6B in fiscal 2016 to $6.5B in fiscal 2025, growth of about 6.8% a year.
Net income in fiscal 2025 was $4.1B, a net margin of 62.5%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $7.0B and net income $4.4B.
Free cash flow was $4.2B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 6% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.0B | $6.5B | $6.1B | $5.6B | $5.0B | $4.7B | $4.9B | $4.9B | $4.3B | $3.6B | $3.6B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $4.6B | $4.2B | $3.9B | $3.4B | $3.0B | $2.6B | $2.6B | $2.6B | $2.6B | $2.3B | $2.2B |
| Net income | $4.4B | $4.1B | $3.5B | $3.2B | $2.7B | $2.6B | $2.1B | $2.1B | $2.0B | $4.1B | $1.5B |
| EPS (diluted) | $12.19 | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 | $5.87 | $5.91 | $5.71 | $11.94 | $4.53 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +6.4% | +9.9% | +11.2% | +7.0% | −4.0% | +0.3% | +13.0% | +18.2% | +1.4% | +8.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.4B | $4.3B | $3.7B | $3.5B | $3.1B | $2.4B | $2.7B | $2.7B | $2.4B | $1.8B | $1.7B |
| Capital spending | -$94M | -$84M | -$94M | -$76M | -$90M | -$127M | -$198M | -$246M | -$117M | -$82M | -$92M |
| Free cash flow | $4.3B | $4.2B | $3.6B | $3.4B | $3.0B | $2.3B | $2.5B | $2.4B | $2.3B | $1.7B | $1.6B |
| Dividends paid | $4.1B | $3.9B | $3.6B | $3.2B | $2.6B | $2.2B | $2.1B | $1.7B | $2.1B | $2.0B | $1.8B |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $100M | $95M | $90M | $83M | $84M | $75M | $96M | $73M | $96M | $58M | $66M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $4.5B | $3.0B | $3.0B | $2.8B | $2.9B | $1.7B | $1.6B | $1.4B | $2.0B | $2.0B |
| Debt | — | $3.4B | $3.4B | $3.4B | $3.4B | $3.4B | $3.4B | $4.3B | $4.4B | $2.2B | $2.2B |
| Equity | — | $28.7B | $26.5B | $26.7B | $26.9B | $27.4B | $26.3B | $26.1B | $25.9B | $22.4B | $20.3B |
| Total assets | — | $198.4B | $137.4B | $129.7B | $174.2B | $196.8B | $124.7B | $75.2B | $77.5B | $75.8B | $69.4B |
| Shares (diluted) | 359M | 360M | 360M | 360M | 359M | 359M | 359M | 358M | 344M | 340M | 339M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 65.7% | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% | 54.0% | 53.2% | 60.5% | 63.4% | 61.2% |
| Net margin | 63.3% | 62.5% | 57.5% | 57.8% | 53.6% | 56.2% | 43.1% | 43.5% | 45.5% | 111.5% | 42.7% |
| FCF margin | 62.1% | 64.3% | 58.7% | 60.5% | 59.1% | 48.5% | 51.6% | 49.9% | 53.9% | 45.8% | 45.6% |
| ROIC | — | 10.1% | 10.2% | 8.8% | 7.7% | 6.7% | 6.9% | 6.7% | 6.1% | 7.4% | 6.5% |
| ROE | — | 14.2% | 13.3% | 12.1% | 10.0% | 9.6% | 8.0% | 8.1% | 7.6% | 18.1% | 7.5% |
Frequently asked questions
What is CME Group’s annual revenue?
$6.5B in fiscal 2025 and $7.0B over the twelve months to September 30, 2026.
How much profit does CME Group make?
Net income was $4.1B in fiscal 2025 (net margin 62.5%).
Is CME Group’s revenue growing?
Yes: revenue rose 6.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.